REG - Zotefoams PLC - Board Changes

ZotefoamsAnnouncement

29/09/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230929:nRSc0421Oa&default-theme=true

RNS Number : 0421O  Zotefoams PLC  29 September 2023

Zotefoams plc

('Zotefoams', the 'Company' or 'Group')

 

Board changes

29 September 2023 - Zotefoams (LSE: ZTF), a world leader in cellular materials
technology, is pleased to announce the appointment of Malcolm Swift as a
Non-Executive Director of the Company and Chair of the Remuneration Committee
with effect from 29 September 2023, following a search process led by the
Chair of the Company and supported by Korn Ferry. Malcolm will also join the
Audit and Nomination Committees.

 

Malcolm is an Executive Vice President of McCormick & Co, a company listed
on NYSE, from which he will retire at the end of 2023. He joined the company
in 2005 and has held a series of executive positions, including President
Global Flavour Solutions and Chief Administrative Officer. He is President of
the European Brands Association, an organisation representing 2,500 businesses
in Europe, from SMEs to multinationals and has held Non-Executive
directorships with Devro plc and Stolt Sea Farm Holdings plc.

 

Zotefoams also announces that Dr Alison Fielding has informed the Board of her
intention to step down as Non-Executive Director and Chair of the Remuneration
Committee with effect from 29 September 2023 to devote more time to her other
activities.

 

Commenting on Malcolm's appointment and Alison's departure, Dr Lynn Drummond,
Chair of the Company commented:

 

"I am delighted to welcome Malcolm to the Zotefoams Board of Directors. His
international experience and extensive B2B skill sets will support our growth
agenda and he will be a valuable addition to the Board. I am looking forward
to working with him.

 

"Ali leaves with our sincerest thanks for her insightful contribution to
strategic and commercialisation issues. We also appreciate her leadership of
the Remuneration Committee, including the recent shareholder consultation for
our Remuneration Policy renewal, which received 97% approval. We wish her well
for the future."

 

Malcolm Swift said: "Zotefoams' ambitious strategy, unique environmentally
friendly technology and global markets present significant opportunities for
growth. I am delighted to be part of the next stage of a business focused on
delivering long-term, sustainable returns in the interests of all its
stakeholders."

 

There is no further information which would require disclosure under LR9.6.13
of the Listing Rules of the Financial Conduct Authority.

 

 

Enquiries:

 

 Zotefoams plc                +44 (0) 208 664 1600
 David Stirling, Group CEO
 Gary McGrath, Group CFO

 IFC Advisory                 +44 (0) 203 934 6630
 Graham Herring

 Tim Metcalfe

 Zach Cohen

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology
delivering optimal material solutions for the benefit of society. Utilising a
variety of unique manufacturing processes, including environmentally friendly
nitrogen expansion for lightweight AZOTE(®) polyolefin and ZOTEK(®)
high-performance foams, Zotefoams sells to diverse markets worldwide.
Zotefoams uses its own cellular materials to manufacture T-FIT(®) advanced
insulation for demanding industrial markets. Zotefoams also owns and licenses
patented microcellular foam technology to reduce plastic use in extrusion
applications and for ReZorce(®) mono-material recyclable barrier packaging.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites
in Kentucky, USA, Brzeg, Poland (foam manufacture), Oklahoma, USA (foam
products manufacture and conversion), Massachusetts, USA, Stilling, Denmark
(microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com (http://www.zotefoams.com)

AZOTE(®), ZOTEK(®), ReZorce(®) and T-FIT(®) are registered trademarks of
Zotefoams plc.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOABXGDCSBDDGXI